Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Prous Science Puts Postgraduate Training Online

Dec. 1, 2000

Protherics' angiotensin vaccine heads for phase II

Dec. 1, 2000

FDA grants orphan drug status for Eurogene's Trinam

Nov. 30, 2000

Piperidine-based renin inhibitors and their use described by Roche

Nov. 29, 2000

TP-10 undergoes phase II evaluation in adult cardiac surgery patients

Nov. 29, 2000

Quinolone derivative exerts significant inotropic/vasodilating effects

Nov. 28, 2000

Cardioselective antimuscarinic agent MF-10058 in development for cardiac conduction disorders

Nov. 28, 2000

Webcasts from AHA Scientific Sessions now available

Nov. 27, 2000

Patient enrollment and initial treatment completed in PRESTO trial

Nov. 27, 2000

Preclinical data show NO-aspirin efficacy in preventing vein graft failure

Nov. 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.